Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 9:13:915424.
doi: 10.3389/fendo.2022.915424. eCollection 2022.

Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation

Affiliations

Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation

Xue Jiang et al. Front Endocrinol (Lausanne). .

Abstract

Objectives: To investigate the cumulative live birth rate (CLBR) according to lipid metabolism in patients with or without polycystic ovarian syndrome (PCOS) undergoing their first complete in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles.

Patients: A total of 1,470 patients with PCOS and 3,232 patients without PCOS who underwent their first complete IVF/ICSI cycles from January 2016 to June 2018 were included. During a minimum of 2 years of follow-up, they had achieved at least one live birth or used all available embryos. The cumulative pregnancy outcomes were compared based on the patients' blood lipid parameters, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), in the two populations. Patients with an abnormal level of one or more of these four indicators were considered the dyslipidemia group. Patients whose four indicators were normal were considered the control group.

Results: Among 1,470 patients with PCOS, the cumulative pregnancy outcomes were similar in the dyslipidemia group and control group. Logistic regression analysis showed that the TC levels were significantly negatively associated with the cumulative live birth rate (CLBR) after adjustment for confounding factors such as age and BMI (aOR 0.81, 95% CI 0.66-0.98, P<0.05). Among the 3,232 patients without PCOS, there was no significant difference in the cumulative pregnancy outcomes between the dyslipidemia group and the control group. No significant correlations were found in other logistic regression analyses.

Conclusions: TC negatively impacts the CLBR after first ovarian stimulation in PCOS patients. PCOS patients with dyslipidemia caused by elevated TC may have a poor CLBR.

Keywords: assisted reproductive technology; cumulative live birth rate; dyslipidemia; lipid metabolism; polycystic ovary syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors state that the study was conducted without any commercial or financial relationships that could be interpreted as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of patient selection.
Figure 2
Figure 2
Logistic regression analysis of the effects of dyslipidemia and lipid parameters on cumulative pregnancy outcomes in PCOS patients.
Figure 3
Figure 3
Logistic regression analysis of the effects of dyslipidemia and lipid parameters on cumulative pregnancy outcomes in non-PCOS patients.

Similar articles

Cited by

References

    1. Azziz R. Polycystic ovary syndrome. Obstet Gynecol (2018) 132:321–36. doi: 10.1097/AOG.0000000000002698 - DOI - PubMed
    1. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil steril (2008) 89:505–22. doi: 10.1016/j.fertnstert.2007.09.041 - DOI - PubMed
    1. Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health (2015) 7:745–63. doi: 10.2147/IJWH.S70314 - DOI - PMC - PubMed
    1. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update (2006) 12:13–21. doi: 10.1093/humupd/dmi036 - DOI - PubMed
    1. Kalra S, Aggarwal S, Khandelwal D. Thyroid dysfunction and dysmetabolic syndrome: the need for enhanced thyrovigilance strategies. Int J Endocrinol (2021) 2021:9641846. doi: 10.1155/2021/9641846 - DOI - PMC - PubMed